These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26756388)

  • 1. Gene polymorphisms and therapy in rheumatoid arthritis.
    Castañeda S; López-Mejías R; González-Gay MA
    Expert Opin Drug Metab Toxicol; 2016; 12(3):225-9. PubMed ID: 26756388
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
    Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF
    Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P; McLeod H
    J Rheumatol; 2010 May; 37(5):1064; author reply 1065. PubMed ID: 20439524
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetic approaches to rheumatoid arthritis.
    Taniguchi A; Kamatani N
    Pharmacogenomics J; 2004; 4(6):350-3. PubMed ID: 15249925
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
    Dervieux T
    J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
    [No Abstract]   [Full Text] [Related]  

  • 6. Current concepts in the genetic diagnostics of rheumatoid arthritis.
    Nagy ZB; Csanád M; Tóth K; Börzsönyi B; Demendi C; Rigó J; Joó JG
    Expert Rev Mol Diagn; 2010 Jul; 10(5):603-18. PubMed ID: 20629510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics in rheumatoid arthritis.
    Sen D; Paul JR; Ranganathan P
    Methods Mol Biol; 2014; 1175():625-60. PubMed ID: 25150878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on methotrexate pharmacogenetics in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2008 Apr; 9(4):439-51. PubMed ID: 18384257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases.
    Mena JP; Salazar-Páramo M; González-López L; Gámez-Nava JI; Sandoval-Ramirez L; Sánchez JD; Figuera LE; Muñoz-Valle FJ; Vazquez del Mercado M; Dávalos IP
    Pharmacogenomics J; 2011 Aug; 11(4):287-91. PubMed ID: 20514079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of biological treatment in rheumatoid arthritis.
    Xie X; Zhang D; Chen JW; Tian J; Ling GH; Li F
    Expert Opin Biol Ther; 2014 Feb; 14(2):157-64. PubMed ID: 24295560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
    Kooloos WM; Wessels JA; van der Straaten T; Allaart CF; Huizinga TW; Guchelaar HJ
    Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
    Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
    J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and the impact on treatment protocols in patients with rheumatoid arthritis.
    Ibrahim I; Owen SA; Barton A
    Expert Rev Clin Immunol; 2012 Aug; 8(6):509-11. PubMed ID: 22992143
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigating the role of CD24 gene polymorphisms in rheumatoid arthritis.
    Sánchez E; Fernández-Gutierrez B; González-Gay MA; Balsa A; García A; Rodríguez L; Pascual-Salcedo D; González-Escribano MF; Martin J
    Ann Rheum Dis; 2008 Aug; 67(8):1197-8. PubMed ID: 18621973
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatoid arthritis etiology and HLA-linked odorant receptor gene polymorphisms: comment on the article by Klareskog et al.
    Ziegler A; Uchańska-Ziegler B
    Arthritis Rheum; 2006 Aug; 54(8):2705-6. PubMed ID: 16871554
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic epidemiology of rheumatoid arthritis.
    Oliver JE; Worthington J; Silman AJ
    Curr Opin Rheumatol; 2006 Mar; 18(2):141-6. PubMed ID: 16462519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
    Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
    Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor polymorphisms in Korean patients with rheumatoid arthritis.
    Lee EB; Kim JY; Lee YJ; Song YW
    Ann Rheum Dis; 2005 Mar; 64(3):503-4. PubMed ID: 15708906
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
    Kooloos WM; de Jong DJ; Huizinga TW; Guchelaar HJ
    Drug Discov Today; 2007 Feb; 12(3-4):125-31. PubMed ID: 17275732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised treatment of arthritis in the next eRA.
    Tas SW
    Neth J Med; 2009 Dec; 67(11):362-3. PubMed ID: 20009111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.